MWM
GILD icon

Manske Wealth Management’s Gilead Sciences GILD Stock Holding History

Manske Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
8,591
+45
+0.5% +$5.93K 0.27% 71
2026
Q1 		$1.19M Buy
8,546
+1
+0% +$140 0.33% 62
2025
Q4 		$1.05M Sell
8,545
-1,005
-11% -$122K 0.31% 63
2025
Q3 		$1.06M Sell
9,550
-58
-0.6% -$6.59K 0.33% 60
2025
Q2 		$1.07M Buy
9,608
+22
+0.2% +$2.34K 0.35% 55
2025
Q1 		$1.07M Sell
9,586
-389
-4% -$40.1K 0.41% 52
2024
Q4 		$921K Buy
+9,975
New +$898K 0.37% 57

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manske Wealth Management's GILD Position: Q2 2026 in Review

Manske Wealth Management increased its Gilead Sciences (GILD) stake by 0.53% in Q2 2026, buying an estimated $5.93K and bringing the position to 8,591 shares worth $1.09M. The position accounts for 0.27% of the portfolio, ranked #71.

Manske Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Manske Wealth Management held 8,591 shares of Gilead Sciences worth $1.09M as of Q2 2026.
  • Manske Wealth Management bought 45 Gilead Sciences shares in Q2 2026, an estimated $5.93K.
  • Gilead Sciences made up 0.27% of Manske Wealth Management's portfolio in Q2 2026, its #71 holding.
  • Manske Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Manske Wealth Management's Gilead Sciences position peaked at $1.19M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.